Boards & Committees - Board of Directors
BOARD OF DIRECTORSEXECUTIVE OFFICERS:
The ISHLT Board of Directors is comprised of 15 individuals: the four Officers (Past President, President, President-Elect, and Secretary-Treasurer) and eleven Directors, reflecting the geographic and disciplinary constituencies of the Society.
The Editor of the Journal of Heart and Lung Transplantion, the Medical Director of the Registry, the Annual Meeting Scientific Program Chair, the Chair of the Development Committee, and the Executive Director serve as ex-officio, non-voting members of the Board.
University of Wisconsin
Madison, WI, USA
email@example.comMaryl R. Johnson, MD, received her medical degree from the University of Iowa College of Medicine where she also completed postgraduate training in Internal Medicine and Cardiovascular Diseases. She joined the faculty at Iowa and was instrumental in the establishment of a cardiac transplant program, serving as the Medical Director of Cardiac Transplantation from 1984-1988. Her subsequent career has been entirely devoted to the care of patients with heart failure and following cardiac transplantation. She served as the Associate Medical Director of the Cardiac Transplant Program at Loyola University Medical Center from 1988-1994, Associate Medical Director of the Rush Heart Failure and Cardiac Transplant Program from 1994-1997, and Medical Director, Heart Failure and Transplantation at Northwestern Memorial Hospital from 1998-2002. She moved to the University of Wisconsin as Medical Director of Heart Failure and Transplantation and Professor of Medicine in July 2002. Dr. Johnson's clinical interests are in the care of patients with severe congestive heart failure, including the use of mechanical circulatory support devices and cardiac transplantation. She has a particular interest in the treatment and outcome of congestive heart failure in women. Her research interests include the use of mechanical assistance in patients with severe heart failure and the coronary artery disease which develops in cardiac transplant recipients. She has also been an investigator in many of the multicenter trials evaluating new agents for the medical treatment of heart failure.
Newcastle Upon Tyne, UK
firstname.lastname@example.orgAndrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.DIRECTORS:
University Hospital Zurich
Zurich, SWITZERLANDchristian_benden@yahoo.deDr. Christian Benden is the Medical Director of Lung Transplantation at the University Hospital Zurich and a Reader in Pulmonology and Transplant Medicine at the University of Zurich, Switzerland. Dr. Benden completed his pediatric training in Hannover (Germany) and London (United Kingdom). In addition, he trained in Pediatric Pulmonology and received specialist training in lung transplantation in London and Zurich. Dr. Benden is a well-recognized Pediatric Lung Transplant Physician, and a former Chair of the ISHLT Scientific Council on Pediatric Transplantation. His research interests include clinical aspects of lung transplantation, particularly in children and adolescents, experimental aspects of chronic lung allograft dysfunction, and cystic fibrosis lung disease.
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, USA
513-636-9101Lara.Danziger-Isakov@cchmc.orgLara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is Associate Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at Saint Louis Children's Hospital. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on pediatric and adult lung transplantation. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate both new infectious disease therapies and new method of detection for infectious diseases.
Heart and Diabetes Center NRW
Bad Oeynhausen, GERMANY
05731 / 97 email@example.comBio coming soon...
Montefiore Medical Center
Bronx, New York, USA
firstname.lastname@example.orgDr. Daniel J. Goldstein is a Professor at the Albert Einstein College of Medicine and Vice Chairman of the Department of Cardiothoracic Surgery at Montefiore Medical Center in New York where he also serves as the Director of the Mechanical Assistance Program. He is a graduate of the Mount Sinai School of Medicine (1991) and completed his general surgery and cardiothoracic surgery training at Columbia Presbyterian Medical Center in New York in 2000. While clinically active in all aspects of adult cardiothoracic surgery including coronary, valvular and aneurysmal heart disease, his clinical and research interests focus on the surgical management of end stage heart disease including stem cell therapies and pharmacological adjuncts for induction of left ventricular recovery in patients supported with left ventricular assist devices. Dr. Goldstein is an active member of the INTERMACS adverse event committee and has partaken as principal site investigator in multiple industry-based and NIH-supported clinical ventricular assist device trials.
The Prince Charles Hospital
61-7-3350-8111Peter_Hopkins@health.qld.gov.auDr Peter Hopkins is the Director of the Queensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. Executive positions are held with the Australian Lung Foundation (PIVOT and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and National Examiners Panel Royal Australian College of Physicians.
University of Minnesota Medical Center
Minneapolis, MN, USA
email@example.comDr. Michael Petty is the Cardiothoracic Clinical Nurse Specialist at the University of Minnesota Medical Center, Minneapolis, MN. He received his initial nursing degree from St. Mary’s Junior College, Minneapolis, MN, and subsequently obtained a Bachelors Degree in Nursing from the University of the State of New York, and a Masters Degree and PhD in Nursing from the University of Minnesota. He began his career as a staff nurse in the Surgical ICU at the University of Minnesota Hospital and Clinic, and has held a variety of clinical, administrative, and industry roles in the subsequent years. Much of his focus and interest during that time has been in the care of patients with cardiovascular disorders requiring medical, surgical, and transplant interventions. He has been an active participant in the Mechanical Circulatory Support community since 1995 including serving as president of the International Consortium of Circulatory Assist Clinicians (ICCAC) in 2013. His clinical research interests focus on thoracic transplant and family caregivers of MCS patients.
University of Pittsburgh/Presbyterian
Pittsburgh, Pennsylvania, USA
firstname.lastname@example.orgJeffrey Teuteberg, MD, is an Assistant Professor of Medicine, Associate Director of the Cardiac Transplant Program, and a member of the Heart Failure/Cardiac Transplant section of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Medical Center, where he specializes in the care of patients with advanced cardiomyopathies, cardiac transplantation, ventricular assist devices and pulmonary hypertension. He has particular interests in advanced heart failure and the transition to cardiac transplantation and ventricular assist devices. Dr. Teuteberg graduated from the University of Chicago, Pritzker School of Medicine, in 1992 and remained at the University of Chicago for his Internal Medicine Residency and general Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg received his Heart Failure and Cardiac Transplant training at Brigham and Women's hospital in Boston.EX-OFFICIO BOARD MEMBERS:
Professor of Medicine, Harvard Medical School
Executive Director, Center for Advanced Heart Disease, Brigham and Women's Hospital
Boston, Massachusetts, USA
email@example.comDr. Mehra, an internationally recognized cardiologist with expertise in the treatment of heart failure and heart muscle damage, cardiac transplantation and mechanical circulatory devices, is professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women's Hospital in Boston, MA (USA). He obtained his cardiovascular training at the Ochsner Clinic Foundation, where he sub-specialized in the field of advanced heart failure and cardiac transplantation. He is board certified in internal medicine and cardiovascular diseases. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease, new immunosuppressive therapy to improve heart transplant outcomes, and bringing genomic and proteomic science (the study of protein interactions in the body) to the bedside. In the field of heart failure, his research has focused on the role of new devices and novel serum markers to guide diagnosis and therapy.
University of Utah
Salt Lake City, Utah, USA
firstname.lastname@example.orgJosef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.
14673 Midway Rd., Suite 200
Addison, Texas, 75001
email@example.comBio coming soon...
Members of the 2016-2017 ISHLT Board of Directors convened in April 2016 at the ISHLT Annual Meeting in Washington, DC.